Loss from change in fair value of embedded derivative liability
0
0
-15
-
Non-cash lease expense
146
143
140
532
Accretion of discounts and amortization of premiums on marketable debt securities, net
481
713
799
2,394
Depreciation expense
8
7
8
31
Decrease (increase) in prepaid expenses, deposits, and other assets
-349
-466
-673
2,095
(decrease) increase in accounts payable
-587
524
-2,515
1,421
Decrease in accrued liabilities
-1,419
-1,388
667
721
Net cash used in operating activities
-13,735
-20,324
-17,430
-69,075
Purchase of marketable debt securities
37,020
26,839
88,890
128,140
Proceeds from maturities of marketable debt securities
49,300
49,653
20,400
113,599
Net cash used in investing activities
12,280
22,814
-68,490
-14,541
Proceeds from exercise of stock options
747
356
946
893
Proceeds from issuance of equity securities in underwritten offering, net of underwriting discounts, issuance of common stock-Underwritten Public Offering
-
-
-
76,194
Proceeds from issuance of equity securities in underwritten offering, net of underwriting discounts, issuance of pre-funded warrants-Pre Funded Warrants-Underwritten Public Offering
-
-
-
21,089
Gross proceeds from issuance of common stock in private placement-Private Placement2024
-
-
-
6,000
Gross proceeds from issuance of common stock in private placement-Private Placement2025
-
-
-
4,210
Payment of offering costs
0
0
35
1,059
Net cash provided by financing activities
747
356
911
107,327
Net decrease in cash and cash equivalents
-708
2,846
-85,009
23,711
Cash and cash equivalents at beginning of period
9,098
9,098
94,107
-
Cash and cash equivalents at end of period
11,236
11,944
9,098
-
Unit: Thousand (K) dollars (except for numbers of shares and EPS). Numbers labeled with * are estimated quarterly values.
Time Plot
Show the time plot by selecting a row from the table.